Paolo Tarantino

43PUBLICATIONS
118CO-AUTHORS
Predictive and prognostic markersMolecular targetsModels of care and place of birthCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Jul 13, 2026
Recurrence risk in HR-positive/HER2-negative early breast cancer: real-world US electronic health records study.

|Feb 06, 2026
Different Diseases, Different Escapes: Trastuzumab Deruxtecan Resistance in HER2-Amplified versus HER2-Low Breast Cancer.

Tess A O'Meara, Paolo Tarantino

|Dec 19, 2025
Molecular and clinical insights of trastuzumab deruxtecan efficacy in advanced breast cancer.

Amin H Nassar, Elias Bou Farhat, Hassan Abushukair

|Aug 14, 2025
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer.

Paolo Tarantino, Do Lee, Julia Foldi

|Jul 30, 2025
Antibody-drug conjugates for treating early-stage breast cancer: current use, anticipated evolutions.

Pooja Patel, Antonio Giordano, Sara Giordano

|May 28, 2025
Management of Metastatic Hormone Receptor-Positive Breast Cancer Beyond CDK4/6 Inhibitors.

Philip D Tracy, Emily Bopp, Emily Milner

Pageof 8

Frequent Collaborators

17 joint publications

Sara M Tolaney

12 joint publications

Giuseppe Curigliano

6 joint publications

Ilana Schlam

5 joint publications

Filipa Lynce